Lorenz Kevin 4
4 · Fortress Biotech, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Lorenz Kevin
Director
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2024-01-01+3,333→ 24,304 total
Holdings
- 666(indirect: By Spouse)
COMMON STOCK, PAR VALUE $0.001
Footnotes (2)
- [F1]Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
- [F2]One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service.